| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |